Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | IM / LA |
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Aching joints; Inappropriate schedule of vaccine administered; Headache; This non-serious case was reported by a consumer via call center representative and described the occurrence of headache in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Co-suspect products included Herpes zoster (Shingrix) for prophylaxis. In AUG-2020, the patient received the 1st dose of Shingrix (intramuscular, left arm) .5 ml. The patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced headache (Verbatim: Headache), joint pain (Verbatim: Aching joints) and incomplete course of vaccination (Verbatim: Inappropriate schedule of vaccine administered). The outcome of the headache was resolved (duration 24 hrs) and the outcome of the joint pain was resolved and the outcome of the incomplete course of vaccination was not applicable. It was unknown if the reporter considered the headache and joint pain to be related to Shingrix. It was unknown if the company considered the headache and joint pain to be related to Shingrix. Additional Information: GSK Receipt Date: 22-SEP-2025 The patient received the 1st dose of Shingrix Vaccine and had headache and aching joints for about 24 hours. She reports she received the vaccine at a local pharmacy. The patient reports she has not received the 2nd dose yet. She inquired, can she get the 2nd dose after 5 years. Batch number "UNK" and follow-up has been requested: The batch number was not provided and a request for this information has been made.